Harvard Bioscience Inc (HBIO) — Cash Flow Reinvestment Rate
Harvard Bioscience Inc (HBIO) has a Cash Flow Reinvestment Rate of 2.12x as of June 2026, reinvesting $688.00K (capex $688.00K ) from operating cash flow of $325.00K. See HBIO free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Harvard Bioscience Inc Cash Flow Reinvestment Rate (1999–2025)
Historical reinvestment intensity for Harvard Bioscience Inc across 27 annual periods. For the full cash flow conversion analysis, see how efficiently does Harvard Bioscience Inc generate cash.
Annual Cash Flow Reinvestment Rate for Harvard Bioscience Inc (1999–2025)
Year-by-year capital reinvestment analysis for Harvard Bioscience Inc. See HBIO financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.17x | $1.11 Million | $6.73 Million | $1.11 Million | ▼ -94.8% |
| 2024 | 3.20x | $4.61 Million | $1.44 Million | $3.26 Million | ▲ +1266.6% |
| 2023 | 0.23x | $3.28 Million | $14.03 Million | $2.31 Million | ▼ -91.5% |
| 2022 | 2.76x | $3.18 Million | $1.15 Million | $1.59 Million | ▲ +29.5% |
| 2021 | 2.13x | $2.69 Million | $1.26 Million | $1.34 Million | ▲ +678.8% |
| 2020 | 0.27x | $2.55 Million | $9.33 Million | $1.15 Million | ▲ +52.4% |
| 2019 | 0.18x | $1.45 Million | $8.05 Million | $1.22 Million | ▼ -99.2% |
| 2018 | 23.37x | $54.78 Million | $2.34 Million | $986.00K | ▲ +1267.1% |
| 2017 | 1.71x | $1.81 Million | $1.06 Million | $890.00K | ▲ +497.2% |
| 2016 | 0.29x | $1.54 Million | $5.38 Million | $1.48 Million | ▼ -93.2% |
| 2015 | 4.22x | $2.98 Million | $705.00K | $2.98 Million | ▲ +816.7% |
| 2014 | 0.46x | $2.00 Million | $4.35 Million | $2.00 Million | ▲ +11.4% |
| 2013 | 0.41x | $1.68 Million | $4.06 Million | $1.68 Million | ▲ +82.1% |
| 2012 | 0.23x | $1.83 Million | $8.06 Million | $1.83 Million | ▼ -4.3% |
| 2011 | 0.24x | $1.51 Million | $6.35 Million | $1.51 Million | ▲ +245.5% |
| 2010 | 0.07x | $844.00K | $12.29 Million | $844.00K | ▼ -17.6% |
| 2009 | 0.08x | $1.38 Million | $16.51 Million | $1.38 Million | ▼ -41.4% |
| 2008 | 0.14x | $1.31 Million | $9.20 Million | $1.31 Million | ▲ +18.0% |
| 2007 | 0.12x | $1.45 Million | $12.05 Million | $1.45 Million | ▼ -57.8% |
| 2006 | 0.29x | $2.39 Million | $8.36 Million | $2.39 Million | ▲ +34.9% |
| 2005 | 0.21x | $1.10 Million | $5.20 Million | $1.10 Million | ▼ -19.6% |
| 2004 | 0.26x | $3.01 Million | $11.44 Million | $3.01 Million | ▼ -60.4% |
| 2003 | 0.67x | $1.35 Million | $2.03 Million | $1.35 Million | ▼ -59.3% |
| 2002 | 1.63x | $1.31 Million | $799.46K | $1.31 Million | ▲ +264.0% |
| 2001 | 0.45x | $1.84 Million | $4.10 Million | $1.84 Million | ▲ +53.1% |
| 2000 | 0.29x | $629.52K | $2.15 Million | $629.52K | ▲ +158.2% |
| 1999 | 0.11x | $332.47K | $2.93 Million | $332.47K | — |